GEN Exclusives

More »

GEN News Highlights

Back to Item »

Access Pharmaceuticals Grants JCOM Korean License to Two Cancer Products

JCOM will market MuGard for oral mucosistis and will fund Phase II trial with ProLindac.

Forward this item to a colleague:


(Separate multiple addresses by commas)


(Separate multiple addresses by commas)


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »